Guerschon Yabusele
CHI
FAge 31Last season rank #370medium confidence
Only 2 NBA seasons of history, so games played is capped below a full-season assumption.
Turnovers per game — 25-26, league-wide. Lower is better.
League Leader0.2
This Player0.6
League Average1.3
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 17-18 | n/a |
| 18-19 | n/a |
| 24-25 | #166 |
| 25-26 | #370 |
| 26-27 Projection | #381 |
Stat Trend
Track role, durability, and category growth by season. Scoring: 9-category
PTS
Full data
| Season | PTS |
|---|---|
| 17-18 | 2.4 |
| 18-19 | 2.3 |
| 24-25 | 11 |
| 25-26 | 5.6 |
| 26-27 Projection | 5.7 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 2 |
| Nov 2025 | 3.1 |
| Dec 2025 | 3.7 |
| Jan 2026 | 1.8 |
| Feb 2026 | 10.1 |
| Mar 2026 | 10.3 |
| Apr 2026 | 9.4 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Depth Chart
Depth Chart
CHI — all five positions, best player first at each spot.
Season History
9-categoryNBA profile
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 31 | CHI | 66 | 0 | 15.1 | #381 | -3.03 | 5.7 | 3.3 | 1 | 0.4 | 0.2 | 1 | 45.1% | 4.5 | 71.2% | 1.1 | 0.6 |
| 25-26 | 30 | CHI | 67 | 0 | 15 | #370 | -3.97 | 5.6 | 3.5 | 0.9 | 0.4 | 0.2 | 1 | 40.1% | 4.7 | 75.0% | 1.1 | 0.6 |
| 24-25 | 29 | PHI | 70 | 0 | 27.1 | #166 | 0.45 | 11 | 5.6 | 2.1 | 0.8 | 0.3 | 1.5 | 50.1% | 8 | 72.5% | 2 | 1.2 |
| 18-19 | 23 | BOS | 41 | 0 | 6.1 | n/a | n/a | 2.3 | 1.3 | 0.4 | 0.2 | 0.2 | 0.2 | 45.5% | 1.9 | 68.2% | 0.5 | 0.4 |
| 17-18 | 22 | BOS | 33 | 0 | 7.1 | n/a | n/a | 2.4 | 1.6 | 0.5 | 0.1 | 0.2 | 0.4 | 42.6% | 1.8 | 68.2% | 0.7 | 0.4 |